Robert Rosenson, Icahn School of Medicine at Mount Sinai, New York, USA, reviews recently published results of the ARCHES-2 trial with zodasiran and the MUIR trial with plozasiran, in patients with mixed hyperlipidaemia.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
